1784 related articles for article (PubMed ID: 27408648)
21. Childhood DNA methylation as a marker of early life rapid weight gain and subsequent overweight.
Robinson N; Brown H; Antoun E; Godfrey KM; Hanson MA; Lillycrop KA; Crozier SR; Murray R; Pearce MS; Relton CL; Albani V; McKay JA
Clin Epigenetics; 2021 Jan; 13(1):8. PubMed ID: 33436068
[TBL] [Abstract][Full Text] [Related]
22. Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthood.
Lillycrop KA; Garratt ES; Titcombe P; Melton PE; Murray RJS; Barton SJ; Clarke-Harris R; Costello PM; Holbrook JD; Hopkins JC; Childs CE; Paras-Chavez C; Calder PC; Mori TA; Beilin L; Burdge GC; Gluckman PD; Inskip HM; Harvey NC; Hanson MA; Huang RC; Cooper C; ; Godfrey KM
Int J Obes (Lond); 2019 May; 43(5):974-988. PubMed ID: 30622309
[TBL] [Abstract][Full Text] [Related]
23. Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways.
Alba-Linares JJ; Pérez RF; Tejedor JR; Bastante-Rodríguez D; Ponce F; Carbonell NG; Zafra RG; Fernández AF; Fraga MF; Lurbe E
Cardiovasc Diabetol; 2023 Mar; 22(1):44. PubMed ID: 36870961
[TBL] [Abstract][Full Text] [Related]
24. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes.
Junien C; Nathanielsz P
Obes Rev; 2007 Nov; 8(6):487-502. PubMed ID: 17949354
[TBL] [Abstract][Full Text] [Related]
25. Roadmap for investigating epigenome deregulation and environmental origins of cancer.
Herceg Z; Ghantous A; Wild CP; Sklias A; Casati L; Duthie SJ; Fry R; Issa JP; Kellermayer R; Koturbash I; Kondo Y; Lepeule J; Lima SCS; Marsit CJ; Rakyan V; Saffery R; Taylor JA; Teschendorff AE; Ushijima T; Vineis P; Walker CL; Waterland RA; Wiemels J; Ambatipudi S; Degli Esposti D; Hernandez-Vargas H
Int J Cancer; 2018 Mar; 142(5):874-882. PubMed ID: 28836271
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in epigenetics of acute and chronic kidney diseases.
Reddy MA; Natarajan R
Kidney Int; 2015 Aug; 88(2):250-61. PubMed ID: 25993323
[TBL] [Abstract][Full Text] [Related]
27. Epigenetics in Human Obesity and Type 2 Diabetes.
Ling C; Rönn T
Cell Metab; 2019 May; 29(5):1028-1044. PubMed ID: 30982733
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Alterations and Prenatal Maternal Depression.
Nemoda Z; Szyf M
Birth Defects Res; 2017 Jul; 109(12):888-897. PubMed ID: 28714605
[TBL] [Abstract][Full Text] [Related]
29. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives.
Milagro FI; Mansego ML; De Miguel C; Martínez JA
Mol Aspects Med; 2013; 34(4):782-812. PubMed ID: 22771541
[TBL] [Abstract][Full Text] [Related]
30. Epigenetics: Linking Early Postnatal Nutrition to Obesity Programming?
Marousez L; Lesage J; Eberlé D
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817318
[TBL] [Abstract][Full Text] [Related]
31. Developmental Origins of Common Disease: Epigenetic Contributions to Obesity.
Kappil M; Wright RO; Sanders AP
Annu Rev Genomics Hum Genet; 2016 Aug; 17():177-92. PubMed ID: 27216778
[TBL] [Abstract][Full Text] [Related]
32. [Epigenetics and obesity].
Casanello P; Krause BJ; Castro-Rodríguez JA; Uauy R
Rev Chil Pediatr; 2016; 87(5):335-342. PubMed ID: 27692574
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.
Holland N; Lizarraga D; Huen K
Curr Opin Pediatr; 2015 Apr; 27(2):240-7. PubMed ID: 25635583
[TBL] [Abstract][Full Text] [Related]
34. Recent progress in epigenetics of obesity.
Wu FY; Yin RX
Diabetol Metab Syndr; 2022 Nov; 14(1):171. PubMed ID: 36397166
[TBL] [Abstract][Full Text] [Related]
35. The Emerging Role of Epigenetics in Inflammation and Immunometabolism.
Raghuraman S; Donkin I; Versteyhe S; Barrès R; Simar D
Trends Endocrinol Metab; 2016 Nov; 27(11):782-795. PubMed ID: 27444065
[TBL] [Abstract][Full Text] [Related]
36. An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions.
Mahmoud AM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163268
[TBL] [Abstract][Full Text] [Related]
37. Adverse Maternal Metabolic Intrauterine Environment and Placental Epigenetics: Implications for Fetal Metabolic Programming.
Lesseur C; Chen J
Curr Environ Health Rep; 2018 Dec; 5(4):531-543. PubMed ID: 30267228
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic programming, early life nutrition and the risk of metabolic disease.
Block T; El-Osta A
Atherosclerosis; 2017 Nov; 266():31-40. PubMed ID: 28950165
[TBL] [Abstract][Full Text] [Related]
39. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM.
Barrès R; Zierath JR
Nat Rev Endocrinol; 2016 Aug; 12(8):441-51. PubMed ID: 27312865
[TBL] [Abstract][Full Text] [Related]
40. Obesity: epigenetic aspects.
Kaushik P; Anderson JT
Biomol Concepts; 2016 Jun; 7(3):145-55. PubMed ID: 27327133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
